NCT07355075: A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

Sponsor: Turn Therapeutics. Phase: PHASE2. Conditions: Eczema Atopic Dermatitis, Eczema, Atopic Dermatitis